QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NYSE:TFX

Teleflex (TFX) Stock Forecast, Price & News

$240.09
+4.11 (+1.74%)
(As of 06/7/2023 ET)
Compare
Today's Range
$234.75
$241.01
50-Day Range
$232.06
$274.11
52-Week Range
$182.65
$286.44
Volume
308,169 shs
Average Volume
316,368 shs
Market Capitalization
$11.26 billion
P/E Ratio
31.30
Dividend Yield
0.57%
Price Target
$273.38

Teleflex MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
13.9% Upside
$273.38 Price Target
Short Interest
Bearish
3.58% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.49mentions of Teleflex in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$742,290 Sold Last Quarter
Proj. Earnings Growth
9.41%
From $13.29 to $14.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

187th out of 982 stocks

Surgical & Medical Instruments Industry

17th out of 97 stocks


TFX stock logo

About Teleflex (NYSE:TFX) Stock

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

Teleflex: FDA Clears Arrow EZ-IO Needle As MR Conditional
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Teleflex (NYSE:TFX) Coverage Initiated at CL King
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Expert Ratings for Teleflex
StockNews.com Begins Coverage on Teleflex (NYSE:TFX)
Teleflex Publishes 2022 Global Impact Report
Teleflex (NYSE:TFX) Upgraded at StockNews.com
See More Headlines

TFX Price History

TFX Company Calendar

Ex-Dividend for 3/15 Dividend
3/02/2023
Dividend Payable
3/15/2023
Last Earnings
5/04/2023
Ex-Dividend for 6/15 Dividend
5/12/2023
Today
6/07/2023
Dividend Payable
6/15/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
15,500
Year Founded
1943

Price Target and Rating

Average Stock Price Forecast
$273.38
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+14.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

Net Income
$363.14 million
Pretax Margin
15.73%

Debt

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$18.04 per share
Book Value
$85.74 per share

Miscellaneous

Free Float
46,239,000
Market Cap
$11.20 billion
Optionable
Optionable
Beta
1.00

Social Links


Key Executives

  • Mr. Liam J. KellyMr. Liam J. Kelly (Age 56)
    Chairman, Pres & CEO
    Comp: $2M
  • Mr. Thomas E. Powell (Age 61)
    Exec. VP & CFO
    Comp: $1.04M
  • Mr. Cameron P. HicksMr. Cameron P. Hicks (Age 58)
    Corp. VP of HR & Communications
    Comp: $564.68k
  • Mr. Jay White (Age 49)
    Corp. VP & Pres of Global Commercial
    Comp: $866.86k
  • Mr. John R. Deren
    Corp. VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy
    VP & Chief Information Officer
  • Mr. John Hsu C.F.A.
    VP of Investor Relations
  • Mr. Daniel V. Logue (Age 49)
    Corp. VP, Gen. Counsel & Sec.
  • Mr. Howard Cyr
    Corp. VP & Chief Compliance Officer
  • Mr. Matt Tomkin
    VP of Corp. Devel.













TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TFX shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price forecast for 2023?

12 analysts have issued 1 year target prices for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $330.00. On average, they anticipate the company's stock price to reach $273.38 in the next twelve months. This suggests a possible upside of 14.5% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 at the start of the year. Since then, TFX shares have decreased by 4.3% and is now trading at $238.81.
View the best growth stocks for 2023 here
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our TFX earnings forecast
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings results on Thursday, May, 4th. The medical technology company reported $3.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.97 by $0.12. The medical technology company had revenue of $710.90 million for the quarter, compared to the consensus estimate of $687.11 million. Teleflex had a trailing twelve-month return on equity of 15.80% and a net margin of 12.68%. The firm's quarterly revenue was up 10.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.88 EPS.
Read the conference call transcript
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Monday, May 8th. Shareholders of record on Monday, May 15th will be given a dividend of $0.34 per share on Thursday, June 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.57%. The ex-dividend date is Friday, May 12th.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 17.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.35% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $13.00-$13.60 for the period, compared to the consensus earnings per share estimate of $13.29. The company issued revenue guidance of $2.92 billion-$2.96 billion, compared to the consensus revenue estimate of $2.93 billion.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.48%), Wellington Management Group LLP (6.60%), State Street Corp (4.96%), Price T Rowe Associates Inc. MD (3.90%), Geode Capital Management LLC (2.07%) and Allspring Global Investments Holdings LLC (1.80%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $238.81.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $11.20 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.67 on an earnings per share basis.

How many employees does Teleflex have?

The company employs 15,500 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -